NCT00438477View on ClinicalTrials.gov

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

April 30, 2008

Conditions
Breast Cancer
Interventions
DRUG

Isosulfan Blue

At time of surgery, breast injected with 3-5 cc of isosulfan blue in subareolar or peritumoral position.

PROCEDURE

Lymphangiography

2 lymphoscintigraphy images performed following peritumoral and subareolar injection of breast

RADIATION

Technetium Tc 99m sulfur colloid

"At least 2 days before scheduled surgery, receive technetium Tc 99m sulfur colloid by peritumoral injection; and again the day before surgery by subareolar injection.~At the time of surgery, patients receive isosulfan blue by subareolar injection."

Trial Locations (1)

77030-4009

M. D. Anderson Cancer Center at University of Texas, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT00438477 - Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer | Biotech Hunter | Biotech Hunter